PCSC vs RLAY

Perceptive Capital Solutions Corp Class A Ordinary Shares (PCSC) offers the better valuation at 37.

6x trailing P/E, making it the more compelling value choice. Analysts rate Relay Therapeutics, Inc. (RLAY) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Perceptive Capital Solutions Corp Class A Ordinary Shares (PCSC) delivered a total return of +12.

2%, compared to -57. 6% for Relay Therapeutics, Inc. (RLAY). Over 10 years, the gap is even starker: PCSC returned +12. 2% versus RLAY's -63. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Perceptive Capital Solutions Corp Class A Ordinary Shares (PCSC) is the lower-risk stock at 0.

22β versus Relay Therapeutics, Inc. 's 1. 77β — meaning RLAY is approximately 710% more volatile than PCSC relative to the S&P 500.

Perceptive Capital Solutions Corp Class A Ordinary Shares (PCSC) is the more profitable company, earning 0.

0% net margin versus -1800. 6% for Relay Therapeutics, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PCSC leads at 0. 0% versus -1971. 6% for RLAY. At the gross margin level — before operating expenses — RLAY leads at 76. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Perceptive Capital Solutions Corp Class A Ordinary Shares (PCSC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

22)). Relay Therapeutics, Inc. (RLAY) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PCSC: +12. 2%, RLAY: -63. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PCSC (Financial Services) and RLAY (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PCSC is a small-cap quality compounder stock; RLAY is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.